Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Hepatology International
Literature
1.
2.
3.
Metadata
Title
Thromboelastometry in patients with advanced chronic liver disease: a complex interplay
Author
Sanchit Sharma
Publication date
01-04-2021
Publisher
Springer India
Published in
Hepatology International / Issue 2/2021
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-021-10142-5

Other articles of this Issue 2/2021

Hepatology International 2/2021 Go to the issue

Original Article

High-normal alanine aminotransferase is an indicator for liver histopathology in HBeAg-negative chronic hepatitis B

Original Article

Clinical manifestations and outcomes of patients with scirrhous hepatocellular carcinoma

Letter to the Editor

C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3

Original Article

Combining end-of-treatment HBsAg and baseline hepatitis B core-related antigen reduce HBV relapse rate after tenofovir cessation

Original Article

The metabolic profiles and body composition of lean metabolic associated fatty liver disease

Guidelines

Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits